Sinopharm COVID-19 vaccine

URI: https://gptkb.org/entity/Sinopharm_COVID-19_vaccine
GPTKB entity
Statements (96)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:administeredBy over 90 countries
gptkbp:age 18 years and older
gptkbp:approvedBy gptkb:United_Arab_Emirates
2020-12-09
gptkbp:boosterRecommended yes
gptkbp:brand gptkb:Sinopharm_BIBP_COVID-19_vaccine
gptkb:BBIBP-CorV
gptkbp:clinicalTrialPhase conducted in UAE, Bahrain, Egypt, Jordan, Peru, Argentina, Morocco
gptkbp:containsAdjuvant aluminum hydroxide
gptkbp:containsDNA no
gptkbp:containsEggProtein no
gptkbp:containsFetalCells no
gptkbp:containsGelatin no
gptkbp:containsGeneticMaterial no
gptkbp:containsHumanCells no
gptkbp:containsInactivatedVirus yes
gptkbp:containsLatex no
gptkbp:containsLiveVirus no
gptkbp:containsMeat no
gptkbp:containsMercury no
gptkbp:containsMicrochips no
gptkbp:containsmRNA no
gptkbp:containsPreservative no
gptkbp:containsProteinSubunit no
gptkbp:containsSpikeProtein no
gptkbp:containsThimerosal no
gptkbp:containsViralVector no
gptkbp:containsWholeVirus yes
gptkbp:developedBy gptkb:Sinopharm
gptkb:Beijing_Institute_of_Biological_Products
gptkbp:dosageInterval 3–4 weeks
gptkbp:dosesRequired 2
gptkbp:effect approximately 79% (clinical trials)
gptkbp:emergencyServices gptkb:Argentina
gptkb:Bahrain
gptkb:Bolivia
gptkb:Cambodia
gptkb:Chile
gptkb:China
gptkb:Colombia
gptkb:Ecuador
gptkb:Egypt
gptkb:Guyana
gptkb:Hungary
gptkb:Indonesia
gptkb:Iraq
gptkb:Jordan
gptkb:Laos
gptkb:Malaysia
gptkb:Mauritius
gptkb:Mongolia
gptkb:Morocco
gptkb:Nepal
gptkb:Pakistan
gptkb:Paraguay
gptkb:Peru
gptkb:Philippines
gptkb:Senegal
gptkb:Serbia
gptkb:Seychelles
gptkb:Singapore
gptkb:Sri_Lanka
gptkb:Thailand
gptkb:Turkey
gptkb:United_Arab_Emirates
gptkb:Uruguay
gptkb:Uzbekistan
gptkb:Vanuatu
gptkb:Venezuela
gptkb:Vietnam
gptkb:World_Health_Organization
gptkb:Yemen
gptkb:Zimbabwe
gptkb:Maldives
https://www.w3.org/2000/01/rdf-schema#label Sinopharm COVID-19 vaccine
gptkbp:includedInCOVAX yes
gptkbp:routeOfAdministration intramuscular injection
gptkbp:sideEffect fever
nausea
diarrhea
fatigue
headache
muscle pain
allergic reaction
chills
rash
pain at injection site
gptkbp:storage 2–8°C
gptkbp:target gptkb:COVID-19
gptkbp:technology gptkb:virus
gptkbp:type inactivated virus vaccine
gptkbp:WHOEmergencyUseListing 2021-05-07
gptkbp:bfsParent gptkb:Sinopharm_BIBP_COVID-19_vaccine
gptkb:COVID-19_Vaccination
gptkbp:bfsLayer 5